- Global Pharma News & Resources

Implantable Cardiac Monitors Market Forecast to 2026 - Medtronic, Biotronik and Angel Medical Systems Dominate in Development -

DUBLIN--(BUSINESS WIRE)--The "Implantable Cardiac monitors (ICM) - Market Insights, Competitive Landscape and Market Forecast - 2026" report has been added to's offering.

This 'Implantable Cardiac Monitors (ICM)-Market Insights, Competitive Landscape and Market Forecast-2026' report delivers an in-depth understanding of the Implantable Cardiac monitors, historical and forecasted patient pool as well as the Implantable Cardiac monitors market trends in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom) and Japan.

The report provides an overview of Implantable Cardiac monitors and their applications, market share of the individual devices, current and forecasted Implantable Cardiac monitors market Size from 2018 to 2026, segmented by seven major markets. The Report also covers current market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.

Implantable Cardiac monitors Overview

Implantable Cardiac monitors (ICM) also called implantable loop recorders, are needed to assist physicians in diagnosing the cardiac rhythm of the patients, ensuring that the patient has a healthy and well-functional heart. ICM is used in continuous monitoring of the heart in case of adverse conditions such as atrial fibrillation, heart failure etc.

The monitoring can be performed in a continuous fashion for a period of two to three years, owing to the advanced level batteries with maximized durability. Hence, these devices can be used adequately in patients that require extended periods of monitoring and treatment like infrequent arrhythmias. The preference for implantable cardiac monitors is increasing at a drastic rate, owing to the limited patient stay at the hospital or clinics after surgical procedures, the cost-effectiveness of these medical devices and the escalating aging population.

Implantable Cardiac Monitors - Competitive Analysis

This segment of the report provides a brief competitive analysis of Implantable Cardiac Monitors, to help understand the competition in the market. It gives a comparative understanding of the products based on their application and approval.

Implantable Cardiac Monitor: Market Analysis

This segment illustrates the market of Implantable cardiac monitors across 7MM and how the market is expected to change in the study period (2018 to 2026), at a significant CAGR.

Implantable Cardiac monitors: Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers that have affected the Implantable Cardiac Monitor (ICM) Market.

The growth of ICM market is driven by the increasing demand of Implantable cardiac monitors in patients suffering from heart failure and cardiac arrhythmias, advancements in technology owing to easier implantable procedures, increase in the number of cardiovascular patients, miniaturization of ICM and less time taking procedures to implant the device. However, rising costs of the ICM devices and preference for drugs rather than implantation of treatment devices are some of the barriers that can obstruct the propelling growth of the ICM market.

Industry Trends

There have been various developments and collaborations in the field of implantable cardiac monitors.

  • On 7th July 2020, Medtronic Company received the U.S Food and Drug Administration (FDA) and CE Mark approval for its device LINQ II insertable cardiac monitor composed with remote programming function. In January 2019, the remote monitoring company Geneva Healthcare announced the acquisition of Geneva Healthcare, creator of a remote monitoring platform for implantable cardiac devices, for about USD 45 million in upfront cash with additional performance-based earn-out considerations of no less than USD 20 million.
  • On May 20, 2020, Biotronik had announced its new alliance with Acutus Medical to create a profound portfolio of electrophysiology, mapping, ablation, and accessory products for the catheter-based treatment of cardiac arrhythmias across different markets that also included Europe and Asia. The main objective of this new alliance was to optimize patient care by combining the plethora of devices and monitors that would be linked digitally. This can take place via Biotronik's Home monitoring network with the Acutus system to help transmit real-time data between physicians and patients (DAIC, 2020).
  • Angel Medical Systems had partnered with Flextronics, a leading Electronics Manufacturing Services (EMS) provider that had helped as its manufacturing partner in the development of their product AngelMed Guardian system (Med Device Online, 2012).

Key Topics Covered:

1 Key Insights

2 Executive Summary of Implantable Cardiac Monitors

3 Implantable Cardiac Monitors: Background and Overview

4. Company Profiles

5 Patient Testimony

6 Implantable Cardiac Monitors Devices: Competitive Analysis

7 Assumptions and Rationale- Eligible Patient Population and Market Analysis for Implantable Cardiac Monitors Devices

8 Vagus Nerve Stimulator devices: Eligible Patient Population

9 Implantable Cardiac Monitors Devices: Market Analysis

10. Market Drivers

11. Market Barriers

12. Industry Trends

13. KOL's Views

14. Analyst Views

15. PEST Analysis

16. Appendix

Companies Mentioned

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Medtronic plc
  • Angel Medical Systems Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 18-Aug-2021